Skip to main content

Bavencio

avelumab
Used for Skin Cancer
Used for Skin Cancer

Bavencio (avelumab) is an immunotherapy medication that’s used for several types of cancers like bladder cancer and kidney cancer. It can also be used for a certain type of skin cancer called Merkel cell carcinoma. Bavencio (avelumab) is most often used by itself, but it can also be used with other anticancer medications in some situations. Some of the more common side effects of Bavencio (avelumab) include tiredness, muscle pain, and joint pain. This medication can also cause serious side effects, like infusion reactions and severe diarrhea.

Last reviewed on June 22, 2023
basics-icon

What is Bavencio (avelumab)?

What is Bavencio (avelumab) used for?

How Bavencio (avelumab) works

Bavencio (avelumab) is a type of immunotherapy called a PD-L1 inhibitor. It works against a specific protein on cancer cells called programmed cell death ligand 1 (PD-L1). Cancer cells that have PD-L1 can hide from the body’s immune system. This means that the immune system can’t detect, attack, and kill these cancer cells. As a result, the cancer is able to grow.

When Bavencio (avelumab) attaches to PD-L1 on cancer cells, the cancer cells can’t hide from the immune system anymore. This helps the immune system find and kill cancer cells better. This type of immunotherapy is also known as an immune checkpoint inhibitor.

Drug Facts

Common BrandsBavencio
Drug ClassPD-L1 inhibitor
Controlled Substance ClassificationNot a controlled medication
Generic StatusNo lower-cost generic available
AvailabilityPrescription only
basics-icon

What are the side effects of Bavencio (avelumab)?

The following side effects may get better over time as your body gets used to the medication. Let your healthcare provider know immediately if you continue to experience these symptoms or if they worsen over time.

Common Side Effects

  • Diarrhea (up to 62%)
  • Fatigue (up to 53%)
  • High blood pressure (up to 50%)
  • Higher liver enzymes in the blood (up to 50%)
  • Muscle and bone pain (up to 40%)
  • Nausea (up to 34%)
  • Lower appetite (up to 26%)
  • Rash (up to 25%)
  • Low thyroid hormone levels (hypothyroidism, up to 25%)
  • Cough (up to 23%)
  • Shortness of breath (up to 23%)
  • Infusion-related reaction (up to 22%)
  • Stomach pain (up to 22%)
  • Headache (up to 21%)
Note: Side effects from treatment depend on what other medications you’re taking for your cancer. Bavencio (avelumab) is sometimes given along with other anticancer medications.

Other Side Effects

  • Swelling in arms, legs, or feet
  • Hand-foot syndrome
  • Mouth sores
  • Hoarse voice
  • Urinary tract infection

Serious Side Effects

Contact your healthcare provider immediately if you experience any of the following.
  • Immune-related side effects: cough, shortness of breath, chest pain, rash, diarrhea, stomach pain, mucus or blood in stool
  • Serious infusion reactions: trouble breathing, itching, hives, flushing, swelling, chest pain, fast heartbeat, dizziness, fainting
  • Heart problems: shortness of breath; swelling in hands, feet, and ankles; new chest pain; feeling dizzy or lightheaded; pain in your arms, neck, or back

Source: DailyMed

The following side effects have also been reported

Side effects that you should report to your care team as soon as possible:

  • Allergic reactions—skin rash, itching, hives, swelling of the face, lips, tongue, or throat
  • Dry cough, shortness of breath or trouble breathing
  • Eye pain, redness, irritation, or discharge with blurry or decreased vision
  • Heart attackpain or tightness in the chest, shoulders, arms, or jaw, nausea, shortness of breath, cold or clammy skin, feeling faint or lightheaded
  • Heart muscle inflammation—unusual weakness or fatigue, shortness of breath, chest pain, fast or irregular heartbeat, dizziness, swelling of the ankles, feet, or hands
  • Hormone gland problems—headache, sensitivity to light, unusual weakness or fatigue, dizziness, fast or irregular heartbeat, increased sensitivity to cold or heat, excessive sweating, constipation, hair loss, increased thirst or amount of urine, tremors or shaking, irritability
  • Infusion reactions—chest pain, shortness of breath or trouble breathing, feeling faint or lightheaded
  • Kidney injury (glomerulonephritis)—decrease in the amount of urine, red or dark brown urine, foamy or bubbly urine, swelling of the ankles, hands, or feet
  • Liver injury—right upper belly pain, loss of appetite, nausea, light-colored stool, dark yellow or brown urine, yellowing skin or eyes, unusual weakness or fatigue
  • Pain, tingling, or numbness in the hands or feet, muscle weakness, change in vision, confusion or trouble speaking, loss of balance or coordination, trouble walking, seizures
  • Rash, fever, and swollen lymph nodes
  • Redness, blistering, peeling, or loosening of the skin, including inside the mouth
  • Sudden or severe stomach pain, bloody diarrhea, fever, nausea, vomiting

Side effects that usually do not require medical attention (report these to your care team if they continue or are bothersome):

pros-and-cons

Pros and cons of Bavencio (avelumab)

thumbs-up

Pros

Short infusion time (only 1 hour)

Given once every 2 weeks

Can take with other anticancer medications to treat kidney cancer

thumbs-down

Cons

Requires regular visits to a hospital or infusion center for treatments

Can cause immune-related side effects that can affect any organ (though most commonly rash and diarrhea)

Not safe during pregnancy since it can harm an unborn baby

pharmacist-tips

Pharmacist tips for Bavencio (avelumab)

pharmacist
  • Each infusion appointment can take a couple hours. The appointment includes the time it takes for you to check in, get any medications before your infusion (“pre-medications”), and get the infusion of Bavencio (avelumab). It’ll also take time for your healthcare provider to watch you for any side effects during and after your infusion.

    • Although rare, you might experience a serious reaction during or shortly after your Bavencio (avelumab) infusion. To help lower your risk of an infusion reaction, you’ll receive pre-medications before each of your first 4 infusions and then as needed. These pre-medications include acetaminophen (Tylenol) and an antihistamine, like diphenhydramine (Benadryl). Let your provider know or get help right away if you experience any symptoms of an infusion reaction, like trouble breathing, hives, flushing, chest pain, fast heartbeat, or dizziness.

      • Make sure you have what you need to be comfortable for your Bavencio (avelumab) infusions. Wear sleeves that are easy to roll up, bring a water bottle to help you stay hydrated, and bring a snack.

        • Stay on track with your Bavencio (avelumab) infusions. You can set calendar reminders or use an app that can help remind you to get your infusions on time. If you miss an infusion appointment, contact your healthcare provider to discuss how to get back on track.

          • Diarrhea is a common side effect of Bavencio (avelumab). If you have diarrhea during treatment, let your healthcare provider know. For mild diarrhea, your provider might recommend over-the-counter medications like loperamide (Imodium A-D). You can also avoid foods that are greasy, fatty, or spicy and eat small, frequent meals to help. But if it’s more severe, you might need to take corticosteroid medications or even take a break from Bavencio (avelumab) treatment. Be sure to stay hydrated by drinking plenty of clear, noncarbonated drinks.

            • Make sure to get any blood work done on time as your healthcare provider instructed you to during treatment with Bavencio (avelumab). These blood tests are important for your provider to check for other side effects that might not be noticeable (e.g., kidney, liver, and thyroid health).

              • If you’re able to become pregnant, you should use birth control while receiving Bavencio (avelumab) and for at least 1 month after the last dose. This medication can cause harm to an unborn baby. Let your provider know right away if you become pregnant during treatment.

                faqs

                Frequently asked questions about Bavencio (avelumab)

                Is Bavencio (avelumab) a kind of chemotherapy?
                No. Chemotherapy is a class of medications that directly kills cancer cells that are quickly multiplying in your body. But Bavencio (avelumab) is a type of immunotherapy. It works differently than chemotherapy. Immunotherapy medications like Bavencio (avelumab) use your body’s own immune system to better find and fight cancer cells.
                How long does my Bavencio (avelumab) infusion take?
                The infusion process for Bavencio (avelumab) can take at least an hour and a half. Before you receive Bavencio (avelumab), your healthcare provider will give you medications, such as an antihistamine and acetaminophen (Tylenol), to lower your risk of potential infusion reactions. This will take about 30 minutes. Then, your provider will give you the Bavencio (avelumab) infusion, which can take about an hour. But how long it takes to complete the infusion depends on how well you tolerate the medication. If you’re experiencing a reaction to the infusion (e.g., rash, trouble breathing, feeling faint), your provider might need to temporarily slow down or stop the infusion to manage your symptoms. This will make the infusion take longer to finish.
                Why does Bavencio (avelumab) cause diarrhea, and what can I do to help with this side effect?
                Diarrhea can happen while you’re taking Bavencio (avelumab) because the medication causes your body’s immune system to ramp up so it can kill cancer cells. But since your immune system is in overdrive, it can also attack and affect other areas of your body like your digestive tract, leading to diarrhea. If diarrhea is mild, you can try taking over-the-counter (OTC) antidiarrheal medications like loperamide (Imodium A-D) and avoid foods that might worsen diarrhea. If diarrhea becomes more serious, you should let your healthcare provider know. They might recommend that you take other medications like corticosteroids to help calm down your immune system. If your diarrhea becomes severe and uncontrollable, your healthcare provider might even recommend that you stop taking Bavencio (avelumab) altogether.
                How long should I take Bavencio (avelumab)?
                Talk with your provider if you’re not sure how long you’ll be taking Bavencio (avelumab). Typically, you'll continue to take Bavencio (avelumab) until it stops working for you (i.e., your cancer doesn’t get better or gets worse) or until you have serious side effects. You might need to pause or stop the medication if you have side effects that you can't tolerate, such as rash, diarrhea, and trouble breathing. Your healthcare provider might also pause or stop your Bavencio (avelumab) treatment if your lab results show that your liver, kidneys, or hormone levels are seriously affected by treatment.
                Is Bavencio (avelumab) safe during pregnancy?
                No, Bavencio (avelumab) isn’t safe to take during pregnancy. Animal studies show that the medication can cause harm to the unborn baby. You should avoid becoming pregnant while receiving Bavencio (avelumab) and for at least 1 month after your last dose. Let your provider know right away if you become pregnant during treatment.
                Is Bavencio (avelumab) safe if I’m breastfeeding?
                There isn’t much information about how Bavencio (avelumab) might affect a nursing baby or your milk supply. But to avoid the potential risk for serious harm, your provider will ask you to stop breastfeeding while you’re taking Bavencio (avelumab) and for at least 1 month after your last dose. Talk with your provider if you have any questions about breastfeeding while receiving this medication.
                GoodRxEducationalIcon

                How to save using GoodRx

                Compare Prices
                1. Compare PricesSpecify your dosage and quantity to find out exactly how much you can save.
                Select your free coupon
                2. Select your free couponYou can use the displayed coupon, or compare prices at other pharmacies near you.
                Show coupon to your pharmacist
                3. Show coupon to your pharmacistPresent your printed or electronic coupon when you pick up your prescription.
                Get free couponLearn more
                warings-icon

                What are the risks and warnings for Bavencio (avelumab)?

                Bavencio (avelumab) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.

                risk-warning

                Immune-related side effects

                • Risk factors: Previous radiation to the chest area | Taking Inlyta (axitinib) at the same time

                  Bavencio (avelumab) works by ramping up your immune system. But as a result, an overactive immune system can attack any area of your body, which can affect how your organs normally work. Some examples of immune-related side effects include rash, lung problems (trouble breathing), diarrhea, and liver problems, among many others. These side effects can become severe or life-threatening. Immune-related side effects most commonly occur during treatment, but can also still happen even after you’ve stopped treatment with Bavencio (avelumab).

                  Your healthcare provider will check for the development of immune-related side effects. They’ll monitor your liver, kidney, and thyroid functions through various lab tests during treatment. They’ll also follow up with you on any symptoms you might have. If you experience immune-related side effects, your healthcare provider will examine you to see how severe your symptoms are. Then, they might recommend that you take other medications, like corticosteroids, or stop taking Bavencio (avelumab) altogether.

                  risk-warning

                  Infusion reactions

                  Bavencio (avelumab) can cause infusion reactions, most commonly fever and chills. In clinical trials with Bavencio (avelumab), about 25% of people experienced an infusion reaction. These reactions are usually mild and tolerable, but in rare cases, they can be serious. They can also happen during or several hours after the infusions. Alert your provider or get medical help right away if you experience any throat tightness, wheezing, trouble breathing, fever, chills, hives, flushing, dizziness, or back or stomach pain.

                  risk-warning

                  Serious heart problems when taken together with Inlyta (axitinib) for advanced kidney cancer

                  Taking Bavencio (avelumab) together with Inlyta (axitinib) can raise your risk for severe and life-threatening heart problems. In studies, these problems have included heart attack and heart failure. Because of this risk, your healthcare provider might check your heart function periodically during treatment. Managing any high blood pressure, high cholesterol, or diabetes that you might have can also help lower your risk of heart problems. If you develop serious heart problems, your healthcare provider might recommend stopping treatment with Bavencio (avelumab). Let your healthcare provider know right away if you experience any new or worsening chest pain, shortness of breath, or swelling in the hands, feet, or ankles.

                  risk-warning

                  Complications of stem cell transplant

                  Taking an immunotherapy medication like Bavencio (avelumab) before or after receiving certain types of stem cell transplants can cause serious and fatal problems. One example of a transplant-related complication is graft-versus-host-disease (GVHD). Let your healthcare provider know if you’ve received a stem cell transplant before taking Bavencio (avelumab). Also notify your provider if you’re planning to have a stem cell transplant after treatment with Bavencio (avelumab).

                  risk-warning

                  Harm to unborn baby

                  Bavencio (avelumab) can harm an unborn baby when taken during pregnancy. Because of this risk, if you can get pregnant, you should use birth control while receiving Bavencio (avelumab) and for at least 1 month after the last dose. Let your provider know right away if you become pregnant during this time.

                  dosage

                  Bavencio (avelumab) dosage forms

                  Typical dosing for Bavencio (avelumab)

                  The typical dose is 800 mg as an infusion through the vein (intravenous or IV) once every 2 weeks.

                  alternatives

                  What are alternatives to Bavencio (avelumab)?

                  There are a number of medications that your doctor can prescribe in place of Bavencio (avelumab). Compare a few possible alternatives below.

                  Get savings updates for Bavencio (avelumab)

                  Receive price alerts, news, and other messages from GoodRx about Bavencio (avelumab) and other healthcare topics and relevant savings offers.

                  By providing your email, you consent to receive marketing communications from GoodRx, which may include content and/or data related to men’s health, women's health, reproductive care, or sexual health. You agree to the GoodRx Terms of Use and acknowledge the Privacy Policy. You can unsubscribe at any time.

                  References

                  Best studies we found

                  American Cancer Society. (2018). What is Merkel cell carcinoma?

                  American Cancer Society. (2020). What are infusion or immune reactions?

                  American Cancer Society. (2020). What is kidney cancer?

                  View All References (10)

                  American Cancer Society. (2022). What is bladder cancer?

                  Cancer.net. (2022). Side effects of immunotherapy.

                  EMD Serono, Inc. (2022). Bavencio- avelumab injection, solution, concentrate [package insert]. DailyMed.

                  Han, Y., et al. (2020). PD-1/PD-L1 pathway: Current researches in cancer. American Journal of Cancer Research.

                  Leukemia & Lymphoma Society. (n.d.). Allogeneic stem cell transplantation.

                  Leukemia & Lymphoma Society. (n.d.). Graft-versus-host disease.

                  National Cancer Institute. (n.d.). PD-L1.

                  National Cancer Institute. (2022). Immune checkpoint inhibitors.

                  National Comprehensive Cancer Network. (2022). Immunotherapy side effects: Immune checkpoint inhibitors.

                  National Comprehensive Cancer Network. (2022). Understanding immunotherapy side effects.

                  GoodRx Health has strict sourcing policies and relies on primary sources such as medical organizations, governmental agencies, academic institutions, and peer-reviewed scientific journals. Learn more about how we ensure our content is accurate, thorough, and unbiased by reading our editorial guidelines.
                  Was this page helpful?

                  Browse medications

                  View All

                  Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.